Literature DB >> 18979087

Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines.

J C Winter1.   

Abstract

BACKGROUND: Although man's first encounters with hallucinogens predate written history, it was not until the rise of the sister disciplines of organic chemistry and pharmacology in the nineteenth century that scientific studies became possible. Mescaline was the first to be isolated and its chemical structure determined. Since then, additional drugs have been recovered from their natural sources and synthetic chemists have contributed many more. Given their profound effects upon human behavior and the need for verbal communication to access many of these effects, some see humans as ideal subjects for study of hallucinogens. However, if we are to determine the mechanisms of action of these agents, establish hypotheses testable in human subjects, and explore the mechanistic links between hallucinogens and such apparently disparate topics as idiopathic psychosis, transcendental states, drug abuse, stress disorders, and cognitive dysfunction, studies in animals are essential. Stimulus control by hallucinogens has provided an intuitively attractive approach to the study of these agents in nonverbal species.
OBJECTIVE: The intent of this review is to provide a brief account of events from the time of the first demonstration of hallucinogen-induced stimulus control to the present. In general, the review is limited to lysergic acid diethylamide (LSD) and the hallucinogenic derivatives of phenethylamine and tryptamine.
RESULTS: The pharmacological basis for stimulus control by LSD and hallucinogenic phenethylamines and tryptamines is serotonergic in nature. The 5-HT(2A) receptor appears to be the primary site of action with significant modulation by other serotonergic sites including 5-HT(2C) and 5-HT(1A) receptors. Interactions with other neurotransmitters, especially glutamate and dopamine, are under active investigation. Most studies to date have been conducted in the rat but transgenic mice offer interesting possibilities.
CONCLUSIONS: Hallucinogen-induced stimulus control provides a unique behavioral tool for the prediction of subjective effects in man and for the elucidation of the pharmacological mechanisms of the action of these agents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18979087     DOI: 10.1007/s00213-008-1356-8

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  156 in total

Review 1.  Serotonergic receptor subtypes and hallucinogen-induced stimulus control.

Authors:  J C Winter; D J Fiorella; D M Timineri; R A Filipink; S E Helsley; R A Rabin
Journal:  Pharmacol Biochem Behav       Date:  1999-10       Impact factor: 3.533

2.  Comparison of psilocin with psilocybin, mescaline and LSD-25.

Authors:  A B WOLBACH; E J MINER; H ISBELL
Journal:  Psychopharmacologia       Date:  1962

3.  Research on psychedelics moves into the mainstream.

Authors:  Kelly Morris
Journal:  Lancet       Date:  2008-05-03       Impact factor: 79.321

4.  Evidence of catecholamine mediation in the "aberrant" behaviour induced by lysergic acid diethylamide (LSD) in the rat.

Authors:  A K Dixon
Journal:  Experientia       Date:  1968-07-15

5.  The action of tryptamine on the dog spinal cord and its relationship to the agonistic actions of LSD-like psychotogens.

Authors:  W R Martin; C G Eades
Journal:  Psychopharmacologia       Date:  1970

6.  A possible correlation between drug-induced hallucinations in man and a behavioural response in mice.

Authors:  S J Corne; R W Pickering
Journal:  Psychopharmacologia       Date:  1967

7.  Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale.

Authors:  R J Strassman; C R Qualls; E H Uhlenhuth; R Kellner
Journal:  Arch Gen Psychiatry       Date:  1994-02

8.  Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline.

Authors:  J B Appel; P M Callahan
Journal:  Eur J Pharmacol       Date:  1989-01-02       Impact factor: 4.432

Review 9.  Human hallucinogenic drug research in the United States: a present-day case history and review of the process.

Authors:  R J Strassman
Journal:  J Psychoactive Drugs       Date:  1991 Jan-Mar

10.  Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.

Authors:  R A Glennon; M Titeler; J D McKenney
Journal:  Life Sci       Date:  1984-12-17       Impact factor: 5.037

View more
  20 in total

Review 1.  Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.

Authors:  Clint E Canal; Drake Morgan
Journal:  Drug Test Anal       Date:  2012-04-19       Impact factor: 3.345

2.  The epidemiology of 5-methoxy- N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption.

Authors:  Alan K Davis; Joseph P Barsuglia; Rafael Lancelotta; Robert M Grant; Elise Renn
Journal:  J Psychopharmacol       Date:  2018-04-30       Impact factor: 4.153

3.  Stimulus control by 5-methoxy-N,N-dimethyltryptamine in wild-type and CYP2D6-humanized mice.

Authors:  J C Winter; D J Amorosi; Kenner C Rice; Kejun Cheng; Ai-Ming Yu
Journal:  Pharmacol Biochem Behav       Date:  2011-05-23       Impact factor: 3.533

4.  Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.

Authors:  Michael B Gatch; Sean B Dolan; Michael J Forster
Journal:  Behav Pharmacol       Date:  2017-08       Impact factor: 2.293

5.  Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.

Authors:  Clinton E Canal
Journal:  Handb Exp Pharmacol       Date:  2018

6.  Investigating the mechanisms of hallucinogen-induced visions using 3,4-methylenedioxyamphetamine (MDA): a randomized controlled trial in humans.

Authors:  Matthew J Baggott; Jennifer D Siegrist; Gantt P Galloway; Lynn C Robertson; Jeremy R Coyle; John E Mendelson
Journal:  PLoS One       Date:  2010-12-02       Impact factor: 3.240

7.  Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats.

Authors:  Michael B Gatch; Margaret A Rutledge; Theresa Carbonaro; Michael J Forster
Journal:  Psychopharmacology (Berl)       Date:  2009-03-14       Impact factor: 4.530

8.  Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences.

Authors:  Theresa M Carbonaro; Matthew W Johnson; Ethan Hurwitz; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2017-11-07       Impact factor: 4.530

9.  Discriminative stimulus effects of N,N-diisopropyltryptamine.

Authors:  Theresa M Carbonaro; Michael J Forster; Michael B Gatch
Journal:  Psychopharmacology (Berl)       Date:  2012-10-16       Impact factor: 4.530

10.  The HIV antiretroviral drug efavirenz has LSD-like properties.

Authors:  Michael B Gatch; Alexey Kozlenkov; Ren-Qi Huang; Wenjuan Yang; Jacques D Nguyen; Javier González-Maeso; Kenner C Rice; Charles P France; Glenn H Dillon; Michael J Forster; John A Schetz
Journal:  Neuropsychopharmacology       Date:  2013-05-24       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.